Haemonetics
269 hedge funds and large institutions have $5.05B invested in Haemonetics in 2020 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 84 increasing their positions, 104 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
269
Holders Change
-29
Holders Change %
-9.73%
% of All Funds
5.94%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
43
Increased
84
Reduced
104
Closed
69
Calls
$12.1M
Puts
$13.7M
Net Calls
-$1.65M
Net Calls Change
-$3.45M
Top Buyers
| 1 |
HM
HealthCor Management
New York
|
+$89.6M |
| 2 |
EC
Eminence Capital
New York
|
+$55.5M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$51.7M |
| 4 |
AAMU
AEGON Asset Management (UK)
Edinburgh,
United Kingdom
|
+$49.8M |
| 5 |
Goldman Sachs
New York
|
+$46.7M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$287M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$39.8M |
| 3 |
Morgan Stanley
New York
|
-$35.1M |
| 4 |
Renaissance Technologies
New York
|
-$25.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$20.1M |
